Back

Longitudinal home self-collection of capillary blood using homeRNA correlates interferon and innate viral defense pathways with SARS-CoV-2 viral clearance

Lim, F. Y.; Kim, S.-Y.; Kulkarni, K. N.; Blazevic, R. L.; Kimball, L. E.; Lea, H. G.; Haack, A. J.; Gower, M. S.; Stevens-Ayers, T.; Starita, L. M.; Boeckh, M.; Schiffer, J. T.; Hyrien, O.; Theberge, A. B.; Waghmare, A.

2023-01-28 infectious diseases
10.1101/2023.01.24.23284913
Show abstract

Blood transcriptional profiling is a powerful tool to evaluate immune responses to infection; however, blood collection via traditional phlebotomy remains a barrier to precise characterization of the immune response in dynamic infections (e.g., respiratory viruses). Here we present an at-home self-collection methodology, homeRNA, to study the host transcriptional response during acute SARS-CoV-2 infections. This method uniquely enables high frequency measurement of the host immune kinetics in non-hospitalized adults during the acute and most dynamic stage of their infection. COVID-19+ and healthy participants self-collected blood every other day for two weeks with daily nasal swabs and symptom surveys to track viral load kinetics and symptom burden, respectively. While healthy uninfected participants showed remarkably stable immune kinetics with no significant dynamic genes, COVID-19+ participants, on the contrary, depicted a robust response with over 418 dynamic genes associated with interferon and innate viral defense pathways. When stratified by vaccination status, we detected distinct response signatures between unvaccinated and breakthrough (vaccinated) infection subgroups; unvaccinated individuals portrayed a response repertoire characterized by higher innate antiviral responses, interferon signaling, and cytotoxic lymphocyte responses while breakthrough infections portrayed lower levels of interferon signaling and enhanced early cell-mediated response. Leveraging cross-platform longitudinal sampling (nasal swabs and blood), we observed that IFI27, a key viral response gene, tracked closely with SARS-CoV-2 viral clearance in individual participants. Taken together, these results demonstrate that at-home sampling can capture key host antiviral responses and facilitate frequent longitudinal sampling to detect transient host immune kinetics during dynamic immune states. One Sentence SummarySelf-blood collection using homeRNA captures temporal dynamics in host transcriptional immune response during acute SARS-CoV-2 infection.

Matching journals

The top 7 journals account for 50% of the predicted probability mass.

1
Nature Communications
based on 483 papers
Top 1%
18.1%
2
iScience
based on 74 papers
Top 0.2%
6.8%
3
Immunity
based on 11 papers
Top 0.1%
6.2%
4
JCI Insight
based on 63 papers
Top 1.0%
5.6%
5
Cell Reports Medicine
based on 49 papers
Top 0.6%
4.8%
6
Scientific Reports
based on 701 papers
Top 39%
4.8%
7
Science Translational Medicine
based on 40 papers
Top 0.5%
4.8%
50% of probability mass above
8
eLife
based on 262 papers
Top 7%
3.0%
9
Nature
based on 58 papers
Top 2%
3.0%
10
Nature Medicine
based on 88 papers
Top 4%
2.6%
11
eBioMedicine
based on 82 papers
Top 0.8%
2.6%
12
Frontiers in Immunology
based on 140 papers
Top 3%
2.5%
13
Cell
based on 28 papers
Top 0.9%
2.4%
14
Science Advances
based on 52 papers
Top 0.9%
2.4%
15
The Journal of Infectious Diseases
based on 137 papers
Top 6%
1.7%
16
Viruses
based on 79 papers
Top 3%
1.4%
17
Clinical Infectious Diseases
based on 219 papers
Top 15%
1.4%
18
mBio
based on 34 papers
Top 2%
1.4%
19
Proceedings of the National Academy of Sciences
based on 100 papers
Top 11%
0.9%
20
PLOS ONE
based on 1737 papers
Top 94%
0.8%
21
Cell Reports
based on 25 papers
Top 2%
0.8%
22
Journal of Clinical Investigation
based on 50 papers
Top 3%
0.8%
23
Science
based on 46 papers
Top 6%
0.8%
24
Science Immunology
based on 15 papers
Top 1%
0.8%
25
PLOS Pathogens
based on 35 papers
Top 2%
0.8%
26
The Journal of Immunology
based on 19 papers
Top 2%
0.8%
27
Clinical & Translational Immunology
based on 14 papers
Top 0.6%
0.8%
28
Nature Immunology
based on 14 papers
Top 1%
0.8%
29
EBioMedicine
based on 21 papers
Top 2%
0.7%
30
Journal of Infection
based on 64 papers
Top 8%
0.7%